Latest News

CGI Inc. (TSX:GIB.A), through CGI Federal, has been awarded a significant U.S. Environmental Protection Agency contract to modernize the EPA's financial management platform using AI and automation. The company has also been named Best in Class for sovereign AI related services in Europe, reflecting its role in AI governance, secure infrastructure, and responsible AI frameworks. For investors watching the growth of AI in government services, CGI Inc. (TSX:GIB.A) sits at an intersection of IT...

What triggered the latest move in FormFactor shares FormFactor (FORM) recently dropped alongside a wider pullback in semiconductor stocks after investors sold on Nvidia’s earnings news, even though the report itself and guidance were described as strong. For you as a shareholder or watcher of the name, this kind of sector driven move raises a practical question: how much of FORM’s volatility reflects broader AI and chip sentiment versus anything specific to the company? See our latest...

Towa Food Service (TSE:3329) has released its Q3 2026 results, reporting revenue of ¥3.5b and basic EPS of ¥27.50 for the quarter, alongside net income of ¥222m. The company’s quarterly revenue has moved from ¥3.1b in Q2 2025 to ¥3.2b in Q4 2025 and then to ¥3.5b in Q3 2026. Over the same period, basic EPS has ranged from ¥17.10 to ¥29.25, giving investors a clearer view of how sales and per share profits are tracking into the current year. With trailing net profit margins slightly lower than...

If you are wondering whether PUMA’s current share price reflects its true worth, you are not alone. Many investors are asking if the stock is pricing in too much pessimism or leaving room for a long term recovery story. PUMA last closed at €23.76, with returns of 2.2% over 7 days, 1.8% over 30 days and 6.1% year to date, set against a 1 year return of a 15.4% decline, a 55.5% decline over 3 years and a 69.4% decline over 5 years. Recent coverage around PUMA has focused on how the brand is...

In February 2026, EMCOR Group reported fourth-quarter 2025 sales of US$4,513.12 million and net income of US$434.61 million, contributing to full-year sales of US$16.99 billion and net income of US$1.27 billion, alongside the completion of its U.K. exit and the acquisition of Miller Electric. The company paired these record results with 2026 guidance calling for revenues of US$17.75 billion to US$18.50 billion and diluted EPS of US$27.25 to US$29.25, setting expectations for performance...

Super Group (NYSE:SGHC) launched the ZAR Supercoin digital payment product in South Africa, expanding beyond its core betting operations. The company received final regulatory approval for the Apricot transaction, which allows it to bring its Sportsbook technology fully in-house. Management raised the annual dividend target alongside updates on record multi regional growth and exits from the US market. Super Group, trading at $10.7, has a reported 3 year return of 196.6% and a 1 year return...

Flight Centre Travel Group’s half-year 2025 results showed sales of A$1,408.48 million and net income of A$60.46 million, alongside a new A$0.12 per-share distribution declared in February 2026 for payment on 16 April 2026. The company highlighted record first-half earnings supported by AI-enabled productivity gains, expanded higher-margin corporate services, and an increased fully franked interim dividend, while maintaining its full-year profit guidance. We’ll now examine how record...

CorMedix (NasdaqGM:CRMD) has agreed to acquire Melinta Therapeutics, adding seven approved therapies to its commercial portfolio. The transaction expands CorMedix's presence in hospital and acute care settings through a broader anti infective offering. The deal marks a shift from a single product focused model toward a multi asset commercial platform. For you as an investor, CorMedix has largely been known for its focus on infection prevention products in high risk settings. By bringing...

Krispy Kreme (DNUT) is back in the spotlight after expanding its collaboration with the Oreo brand, rolling out a limited time cookie themed doughnut collection that sits alongside its recent earnings release. See our latest analysis for Krispy Kreme. The Oreo collaboration and recent earnings update come after a sharp rebound in the short term, with a 7 day share price return of 23.76% and 30 day share price return of 18.67%. However, this sits against a 1 year total shareholder return...

In February 2026, Fluor Corporation reported fourth-quarter 2025 revenue of US$4,175 million with a net loss of US$1,574 million, and a full-year 2025 net loss of US$51 million, after previously reporting net income in the prior year. At the same time, Fluor completed a long-running share repurchase program totaling US$2.98 billions and is working to reshape its risk profile by exiting its majority stake in NuScale Power while maintaining a US$25.5 billions project backlog. Next, we'll...

On December 31, 2025, Thornburg Investment Management Inc. increased its position in Chimera Investment Corp by acquiring 250,000 additional shares, lifting its holding to more than 5.2 million shares and 6.34% of Thornburg’s total Chimera allocation. This expansion of a major institutional position highlights strengthening professional investor interest in Chimera Investment, even as the company continues to work through financial challenges. Next, we’ll examine how Thornburg’s larger...

If you are wondering whether KB Home is priced attractively or already reflects most of its potential, this article is designed to walk you through what the numbers currently suggest about its value. The stock recently closed at US$63.58, with returns of 9.7% over the past month and 11.4% year to date, while the past 3 years show an 86.0% return and the last 5 years show 61.2%. Short term moves such as a 2.6% decline over the past week sit alongside a 6.0% return over the last year. This...

Intro Sino Land (SEHK:83) has opened H1 2026 earnings season with a set of numbers that put revenue and EPS firmly in focus, as investors weigh how the latest figures square with expectations for a business priced at HK$12.78 per share. The company has seen half year revenue move from HK$3,842 million in H2 2024 to HK$3,854 million in H1 2025 and HK$4,329 million in H2 2025, while basic EPS over those periods came in at HK$0.2082, HK$0.209 and HK$0.243 respectively. This gives a clear line of...

In the past week, Applied Materials presented at the SPIE Advanced Lithography and Patterning Conference in San Jose and at Bernstein’s “What’s Next in Tech?” forum in California, highlighting its role in AI-driven semiconductor manufacturing and investor communications. At the same time, sector-wide pressure following Nvidia’s earnings, Broadcom’s 2nm chip milestone, and continued focus on AI and advanced nodes underscored how broader semiconductor sentiment can move Applied Materials’...

Tandem Diabetes Care (TNDM) has been drawing investor attention after a strong month, with the share price returning about 32% over that period and roughly 20% in the past 3 months. See our latest analysis for Tandem Diabetes Care. Against that backdrop, Tandem Diabetes Care’s 32.4% 1 month share price return and 17.4% year to date share price return contrast with a 14.3% 1 year total shareholder return and weaker 3 and 5 year total shareholder returns. This points to momentum building...

TG Therapeutics published five year follow up data from the Phase 3 ULTIMATE I & II studies of BRIUMVI in relapsing forms of multiple sclerosis. The JAMA Neurology paper reports durable clinical efficacy, low relapse rates, and a consistent safety and tolerability profile over the long term. The new data add long horizon evidence for BRIUMVI at a time when the multiple sclerosis treatment market remains highly competitive. TG Therapeutics, trading as NasdaqCM:TGTX, now has five year...

Auckland International Airport (NZSE:AIA) is back in the spotlight after its half year result to December 31, 2025, combining higher sales and revenue with lower net income, as well as a declared dividend and fresh passenger traffic data. See our latest analysis for Auckland International Airport. The recent half year earnings, dividend declaration and steady passenger traffic have come alongside a rising share price, with a 30 day share price return of 12.67% and a 1 year total shareholder...

If you are wondering whether IQVIA Holdings is giving you good value at around US$178.81 per share, this article will help you frame that question with hard numbers rather than headlines. The stock has moved 8.0% over the last 7 days, while returns over 30 days, year to date, 1 year and 3 years sit at 25.4% decline, 20.7% decline, 5.3% decline and 19.0% decline respectively. These price moves sit against a backdrop of ongoing interest in IQVIA's role in contract research, data and technology...

Recent price moves set the stage Resolute Holdings Management (RHLD) has drawn attention after a recent stretch of weaker trading, with the share price down about 10% over the past week and 17% over the past month. See our latest analysis for Resolute Holdings Management. Those short term share price declines sit against a very different longer term picture, with the 1 year total shareholder return around 260%, suggesting earlier buyers have still seen very strong gains despite fading recent...

Guardant Health (NasdaqGS:GH) granted significant inducement equity awards to new employees under its 2023 Employment Inducement Incentive Award Plan following the acquisition of a competitor. The company’s role as a key performance contributor was recently highlighted by the Aristotle Growth Equity Fund, which pointed to the acquisition and robust revenue growth as important drivers. These developments reflect material changes in Guardant Health’s team structure and market positioning that...

bioMérieux (ENXTPA:BIM) just reported full year 2025 results, crossing €4.1b in sales with organic growth ahead of the market, cash flow up 40%, and SPOTFIRE and SMARTBIOME highlighting its diagnostics and food safety offering. See our latest analysis for bioMérieux. The full year results and SMARTBIOME launch appear to have given bioMérieux fresh momentum, with a 1 day share price return of 3.73% and a 7 day share price return of 4.99% at a €100.0 share price. Even so, the year to date share...

Intuit (INTU) has put solid numbers on the board for Q2 2026, with revenue of US$4.7b, basic EPS of US$2.48 and net income of US$693m, backed by trailing 12 month EPS of US$15.53 on revenue of US$20.1b. The company has seen quarterly revenue shift from US$3.9b in Q2 2025 to US$4.7b in Q2 2026, while basic EPS moved from US$1.68 to US$2.48 over the same period. This sets the context for trailing earnings growth of 42.9% and a net margin of 21.6%. For investors, the combination of higher recent...

Fastly (NasdaqGS:FSLY) has emerged as a key player in AI and edge computing, highlighting its role in supporting AI-first applications at the network edge. The company has reached a new profitability milestone after a history of losses, signaling a shift in how its edge cloud platform is being used and monetized. Fastly released a new Global Security Research Report that focuses on cyber risks facing AI-first businesses, calling out rising threats around data integrity, model abuse, and edge...

Enovis (NYSE:ENOV) recorded a goodwill impairment charge of over $500 million in Q4 2025, tied to changes in its business mix and accounting assumptions. The company reported strong organic growth in key segments in the same period, supported by new product launches. Recently introduced products, including the Nebula Stem and OrthoDrive Impactor, are gaining traction, with Nebula competing directly against established peers. For investors tracking Enovis, the combination of a large goodwill...